Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1994-11-04
1997-07-29
Jagannathan, Vasu
Drug, bio-affecting and body treating compositions
Lymphokine
530351, 435 695, 930145, A61K 3819, C07K 1453, C12N 1527
Patent
active
056519630
ABSTRACT:
The present invention relates to the production of CSF-1 heterodimers and pharmaceutical formulations of the heterodimers. The heterodimers can be formed using CSF-1 monomers that have variations in sequence, N or C-terminal processing. For example, CSF/C.gradient.150 can be dimerized with LCSF/C.gradient. 190 to form a heterodimer. Dimerization may occur by separately preparing homodimers and mixing them together under the appropriate conditions. Thereafter, homodimers may be separated from the heterodimers by various chromatographic techniques. Once the heterodimers are isolated, pharmaceutical preparations can be prepared.
REFERENCES:
patent: 4868119 (1989-09-01), Clark et al.
patent: 4879227 (1989-11-01), Clark et al.
patent: 5171675 (1992-12-01), Cerretti et al.
Ralph et al, Cell Immunol 76:10-21 (1983).
Wang et al, J. Cell. Biochem 21:263-275 (1983).
Wells et al, Gene 34:315-323 (1985).
Zoller et al, Nuc. Acids Res. 10(20):6487-6500 (1982).
Das et al, J. Biol. Chem. 257:13679-13684 (1982).
Ladner et al, Embo J. 6(9):2693-2698 (1987).
Wong et al, Science 235:1504-1509 (1987).
Cerretti et al, Mol. Immunol. 25(8)761-770 (1988).
Takahashi et al, Biochem. Biophys. Res. Comm. 152(3):1401-1409 (1988).
Cosman et al, Behring Inst Mitt 83, 1988, pp. 15-26.
Cowgill Cynthia
Halenbeck Robert
Koths Kirston
Laird Walter J.
Blackburn Robert P.
Chiron Corporation
Jagannathan Vasu
McGarrigle, Jr. Philip L.
O'Toole Marshall
LandOfFree
Heterodimers forms of CSF-1 and pharmaceutical compositions ther does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterodimers forms of CSF-1 and pharmaceutical compositions ther, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterodimers forms of CSF-1 and pharmaceutical compositions ther will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-631567